DK3349769T3 - In vivo priming af naturlige killerceller - Google Patents

In vivo priming af naturlige killerceller Download PDF

Info

Publication number
DK3349769T3
DK3349769T3 DK16847576.2T DK16847576T DK3349769T3 DK 3349769 T3 DK3349769 T3 DK 3349769T3 DK 16847576 T DK16847576 T DK 16847576T DK 3349769 T3 DK3349769 T3 DK 3349769T3
Authority
DK
Denmark
Prior art keywords
natural killer
killer cells
vivo priming
priming
vivo
Prior art date
Application number
DK16847576.2T
Other languages
Danish (da)
English (en)
Inventor
Raymond J Tesi
David Moss
Original Assignee
Immune Ventures LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Ventures LLC filed Critical Immune Ventures LLC
Priority claimed from PCT/US2016/061835 external-priority patent/WO2017049327A2/en
Application granted granted Critical
Publication of DK3349769T3 publication Critical patent/DK3349769T3/da

Links

DK16847576.2T 2015-12-07 2016-11-14 In vivo priming af naturlige killerceller DK3349769T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562263951P 2015-12-07 2015-12-07
PCT/US2016/061835 WO2017049327A2 (en) 2015-09-16 2016-11-14 In vivo priming of natural killer cells

Publications (1)

Publication Number Publication Date
DK3349769T3 true DK3349769T3 (da) 2021-03-08

Family

ID=63681977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16847576.2T DK3349769T3 (da) 2015-12-07 2016-11-14 In vivo priming af naturlige killerceller

Country Status (3)

Country Link
JP (1) JP6850297B2 (ja)
DK (1) DK3349769T3 (ja)
ES (1) ES2871100T3 (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1863905T3 (pl) * 2005-03-17 2016-07-29 Ucl Business Plc Sposób aktywacji naturalnych komórek zabójców preparatami komórek guza in vitro
EP2451942A1 (en) * 2009-07-10 2012-05-16 Mark Lowdell Preserved compositions of activated nk cells and methods of using the same
WO2013132256A1 (en) * 2012-03-07 2013-09-12 Ucl Business Plc Compositions and methods for treating viral-mediated infection and disease in immunocompromised individuals

Also Published As

Publication number Publication date
JP2018528276A (ja) 2018-09-27
ES2871100T3 (es) 2021-10-28
JP6850297B2 (ja) 2021-03-31

Similar Documents

Publication Publication Date Title
DK3253865T3 (da) Fremgangsmåder til forbedring af virkningen af terapeutiske immunceller
DK3334422T3 (da) Anvendelse af cannabidiolsyre i behandling af epilepsi
DK3341482T3 (da) Kunstige nukleinsyremolekyler
DK3359214T3 (da) Blodpumpe
DK3289076T3 (da) Præcis sletning af kromosomale sekvenser in vivo
DK3143134T3 (da) Modificerede, naturlige dræberceller og anvendelser deraf
DK3424545T3 (da) Blodpumpe
DK3069739T3 (da) Blodpumpe
DK3134530T3 (da) Behandling af hyperbilirubinæmi
DK3821938T3 (da) Blodpumpe
DK3069740T3 (da) Blodpumpe
DK3234107T3 (da) B-celler til in vivo-levering af terapeutiske midler
KR20180084891A (ko) 구조 조성물 및 방법
DK3394248T3 (da) Dendritisk cellesammensætning
FI20145087A (fi) Parannettu gyroskooppirakenne ja gyroskooppi
DK3107366T3 (da) Priming af frø
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
DK3380313T3 (da) Forbedringer vedrørende fremstillingen af vindmøllevinger
DK3094322T3 (da) Administration af tasimelteon i fastende tilstand
DK3166911T3 (da) Inkorporering af biologiske midler i gødning
DK3365107T3 (da) Cellekultur
DK3237621T5 (da) Varianter af human alpha-galactosidase
DK3164123T3 (da) Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier
DK3303614T3 (da) Forbedret anvendelse af overfladeprimere i klynger
DK3589728T3 (da) Naturlige dræberceller